Spears Abacus Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History
Spears Abacus Advisors LLC
- $4.12 Billion
- Q1 2025
A detailed history of Spears Abacus Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 64,526 shares of REGN stock, worth $36.1 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
64,526
Previous 16,055
301.91%
Holding current value
$36.1 Million
Previous $11.4 Million
257.85%
% of portfolio
0.99%
Previous 0.26%
Shares
5 transactions
Others Institutions Holding REGN
# of Institutions
1,425Shares Held
85.2MCall Options Held
1.39MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.27 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.73 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.17 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.68 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.23 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...